Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T for Advanced Glioma

Advanced Glioma Clinical Trial

Official title: Clinical Study on Evaluation of Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T Cell Injection in Treatment of Advanced Glioma

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to estimate the safety, tolerance and initial efficacy of target IL-13Rα2 or B7-H3 UCAR-T cell injection in the treatment of patients with advanced glioma, as well as the pharmacokinetic characteristics of its metabolites after single and multiple administrations and the biomarkers related to efficacy, safety and drug metabolism.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Advanced Glioma
• Glioma

• NCT number: NCT05752877
• Study type: Interventional
• Source: Second Affiliated Hospital of Soochow University
• Contact: Qing Lan, Doctor
• Phone: +86-512-67784087
• Email: szlq006@163.com
• Status: Recruiting
• Phase: N/A
• Start date: May 1, 2021
• Completion date: April 30, 2026